Barclays’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$24.9K Sell
2025
Q3
$12.5K Buy
2025
Q2
$6.96K Sell
2025
Q1
$17.8K Sell
2024
Q4
$38K Buy
2024
Q3
$56.2K Buy
2024
Q2
$55.6K Sell
2024
Q1
$96.6K Sell
2023
Q4
$130K Buy
2023
Q3
$41.1K Buy
2023
Q2
$27.2K Sell
2023
Q1
$58.8K Sell
2022
Q4
$549K Buy
2022
Q3
$34K Buy
2022
Q2
$21K Sell
2022
Q1
$40K Buy